🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Status
Completed
Location
Knight Cancer Institute at Oregon Health and Science University
Start Date
2005-03
Trial ID
NCT00238433
Part A of this study evaluates iopofosine I 131 (CLR 131) in patients with ...
Status
Active Not Recruiting
Location
Cellectar Biosciences site
Start Date
2017-07-26
Trial ID
NCT02952508
Treatments Being Tested
The primary objective of the study is to evaluate efficacy of entospletinib...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2013-03-14
Trial ID
NCT01799889
Treatments Being Tested
The objective of the study is the evaluation of efficacy and safety of obin...
Status
Terminated
Location
Centrum Onkologii - Instytut im. Marii Skłodowskiej- Curie Klinika Nowotworów Układu Chłonnego
Start Date
2018-05-14
Trial ID
NCT03229382
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
In countries with a high tuberculosis (TB) prevalence, TB and invasive bact...
Status
Completed
Location
Sihanouk Hospital Center of Hope
Start Date
2014-09
Trial ID
NCT02057796
The purpose of this study is to compare brolucizumab (RTH258) ophthalmic so...
Status
Completed
Location
Contact Alcon Call Center for Trial Locations
Start Date
2014-12-08
Trial ID
NCT02307682
Treatments Being Tested
The purpose of the study is to find out the effects and the safety of an in...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2010-03
Trial ID
NCT01090973
Treatments Being Tested
RATIONALE: Studying samples of semen from cancer survivors in the laborator...
Status
Terminated
Location
Vanderbilt-Ingram Cancer Center
Start Date
2010-02
Trial ID
NCT01077440
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab and yttrium Y 90 ibritu...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2003-11
Trial ID
NCT00070447